• Pediatric Asthma Current Perspectives on Individualized Treatment to Optimize Patient Care
  • CME

  • Pediatric Asthma: Current Perspectives on Individualized Treatment to Optimize Patient Care

  • Author(s)/Faculty: Stuart A. Cohen, MD, MPH, FAAP; Michelle B. Lierl, MD; David P Skoner, MD
    Source: Infectious Diseases in Children
    Type: Monograph Articles/Items: 4
    Release Date: 12/1/2011 Expiration Date: 12/1/2012
    Credit Type: CME Number of Credit(s): 1.25
    Cost: Free Provider: Vindico Medical Education

  • Asthma is the most common chronic illness in children. Pediatricians must therefore be knowledgeable of how to diagnose and treat this condition. This monograph will review risk factors for asthma. Criteria for the risk assessment and diagnosis of this disease will be discussed. Guidelines for management of asthma according to disease severity level will be presented, and the efficacy and safety of available treatments will be evaluated.

Sponsorship Statement: This continuing medical education activity is jointly sponsored by Vindico Medical Education and Infectious Diseases in Children

Support Statement: This activity is supported by an independent educational grant from Merck

Target Audience: The intended audience for this activity is pediatricians, pediatric nurse practitioners, and other health care professionals involved in the treatment of pediatric asthma.

Learning Objectives:
At the conclusion of this activity participants should be able to:

  • Develop individualized treatment plans to improve symptom control in children with mild asthma.
  • Apply recent clinical evidence to the management of pediatric patients with unresponsive and/or severe asthma.

Course Chair:
Stan L. Block, MD, FAAP
Editorial Board Member
Infectious Diseases in Children®
President, Kentucky Pediatric/Adult Research
Professor of Clinical Pediatrics
University of Louisville
University of Kentucky
Bardstown, KY

Faculty:
Stuart A. Cohen, MD, MPH, FAAP
Vice-Chair, American Academy Of Pediatrics District 9 (California)
Assistant Professor, University of California San Diego
President, San Diego County Medical Society Foundation
Children’s Primary Care Medical Group, Inc.
San Diego, CA

Michelle B. Lierl, MD
Adjunct Associate Professor
Allergy and Immunology
Cincinnati Children’s Hospital Medical Center
Edgewood, KY

David P. Skoner, MD
Director, Division of Allergy, Asthma, and Immunology
Department of Pediatrics
Allegheny General Hospital
Pittsburgh, PA

Professor of Pediatrics
Drexel University College of Medicine
Philadelphia, PA

Clinical Professor of Pediatrics
West Virginia University School of Medicine
Morgantown, WV

Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Infectious Diseases in Children®. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 1, 2011 to December 1, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Planning Committee and Faculty:
Stan L. Block, MD, FAAP
Stuart A. Cohen, MD, MPH, FAAP
Michelle B. Lierl, MD
David P. Skoner, MD

Peer Reviewer:
Ron Codario, MD, FACP

Medical Writer:
Steve Pridgeon

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
 Stan L. Block, MD, FAAP
Contracted Research: Merck, Novartis

Stuart A. Cohen, MD, MPH, FAAP
Consulting Fees: Ingenix, MedImmune, Novartis, Sanofi,

Michelle B. Lierl, MD
No relevant financial relationships to disclose

David P. Skoner, MD
Consulting Fees: Merck, Sunovion
Grant Support: Greer, GSK, Merck, Novartis
Fees for Non-CME Services: GSK, Merck, Novartis, Sunovion, Teva,

Peer Reviewer reports the following relationship(s):
Ron Codario, MD, FACP
No relevant financial relationships to disclose

Medical Writer reports the following relationship(s):
Steve Pridgeon
No relevant financial relationships to disclose

Vindico Medical Education and Infectious Diseases in Children® staff report the following relationship(s):
 No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2011 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Infectious Diseases in Children® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education or Infectious Diseases in Children®. Neither Vindico Medical Education, Infectious Diseases in Children®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.